vs
Fathom Holdings Inc.（FTHM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Fathom Holdings Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$90.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -7.4%，领先391.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.4%）
Fathom Holdings Inc.是一家总部位于美国的房地产科技与服务企业，为房产经纪人、经纪机构和消费者提供数字交易管理、按揭服务、产权保险、住宅经纪等一站式解决方案，业务覆盖美国大部分区域市场。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FTHM vs RIGL — 直观对比
营收规模更大
FTHM
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出22.4%
-1.2%
净利率更高
RIGL
高出391.4%
-7.4%
两年增速更快
RIGL
近两年复合增速
13.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.6M | $69.8M |
| 净利润 | $-6.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -5.2% | 33.2% |
| 净利率 | -7.4% | 384.0% |
| 营收同比 | -1.2% | 21.2% |
| 净利润同比 | -7.7% | 1769.2% |
| 每股收益（稀释后） | $-0.20 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTHMRIGL
| Q4 25 | $90.6M | $69.8M | ||
| Q3 25 | $115.3M | $69.5M | ||
| Q2 25 | $121.4M | $101.7M | ||
| Q1 25 | $93.1M | $53.3M | ||
| Q4 24 | $91.7M | $57.6M | ||
| Q3 24 | $83.7M | $55.3M | ||
| Q2 24 | $89.2M | $36.8M | ||
| Q1 24 | $70.5M | $29.5M |
净利润FTHMRIGL
| Q4 25 | $-6.7M | $268.1M | ||
| Q3 25 | $-4.4M | $27.9M | ||
| Q2 25 | $-3.6M | $59.6M | ||
| Q1 25 | $-5.6M | $11.4M | ||
| Q4 24 | $-6.2M | $14.3M | ||
| Q3 24 | $-8.1M | $12.4M | ||
| Q2 24 | $-1.3M | $-1.0M | ||
| Q1 24 | $-5.9M | $-8.2M |
毛利率FTHMRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FTHMRIGL
| Q4 25 | -5.2% | 33.2% | ||
| Q3 25 | -3.5% | 40.9% | ||
| Q2 25 | -2.0% | 60.1% | ||
| Q1 25 | -4.8% | 23.9% | ||
| Q4 24 | -7.0% | 28.9% | ||
| Q3 24 | -9.3% | 25.4% | ||
| Q2 24 | -4.1% | 1.2% | ||
| Q1 24 | -8.0% | -23.6% |
净利率FTHMRIGL
| Q4 25 | -7.4% | 384.0% | ||
| Q3 25 | -3.8% | 40.2% | ||
| Q2 25 | -3.0% | 58.6% | ||
| Q1 25 | -6.1% | 21.5% | ||
| Q4 24 | -6.8% | 24.9% | ||
| Q3 24 | -9.7% | 22.5% | ||
| Q2 24 | -1.5% | -2.8% | ||
| Q1 24 | -8.4% | -27.9% |
每股收益（稀释后）FTHMRIGL
| Q4 25 | $-0.20 | $14.11 | ||
| Q3 25 | $-0.15 | $1.46 | ||
| Q2 25 | $-0.13 | $3.28 | ||
| Q1 25 | $-0.24 | $0.63 | ||
| Q4 24 | $-0.29 | $0.82 | ||
| Q3 24 | $-0.40 | $0.70 | ||
| Q2 24 | $-0.07 | $-0.06 | ||
| Q1 24 | $-0.31 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.8M | $155.0M |
| 总债务越低越好 | $5.6M | $52.5M |
| 股东权益账面价值 | $37.4M | $391.5M |
| 总资产 | $78.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.15× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FTHMRIGL
| Q4 25 | $5.8M | $155.0M | ||
| Q3 25 | $9.8M | $137.1M | ||
| Q2 25 | $4.9M | $108.4M | ||
| Q1 25 | $8.0M | $77.1M | ||
| Q4 24 | $7.1M | $77.3M | ||
| Q3 24 | $13.1M | $61.1M | ||
| Q2 24 | $10.4M | $49.1M | ||
| Q1 24 | $5.7M | $49.5M |
总债务FTHMRIGL
| Q4 25 | $5.6M | $52.5M | ||
| Q3 25 | $5.1M | $60.0M | ||
| Q2 25 | $5.1M | $60.0M | ||
| Q1 25 | $5.1M | $60.0M | ||
| Q4 24 | $9.5M | $60.0M | ||
| Q3 24 | $8.8M | $60.0M | ||
| Q2 24 | $3.6M | $60.0M | ||
| Q1 24 | $3.7M | $60.0M |
股东权益FTHMRIGL
| Q4 25 | $37.4M | $391.5M | ||
| Q3 25 | $43.4M | $117.6M | ||
| Q2 25 | $40.7M | $81.9M | ||
| Q1 25 | $43.4M | $18.6M | ||
| Q4 24 | $44.7M | $3.3M | ||
| Q3 24 | $47.1M | $-14.6M | ||
| Q2 24 | $53.1M | $-29.9M | ||
| Q1 24 | $51.9M | $-31.7M |
总资产FTHMRIGL
| Q4 25 | $78.0M | $513.6M | ||
| Q3 25 | $83.2M | $242.5M | ||
| Q2 25 | $80.4M | $206.7M | ||
| Q1 25 | $81.0M | $176.0M | ||
| Q4 24 | $75.4M | $164.0M | ||
| Q3 24 | $80.9M | $139.4M | ||
| Q2 24 | $80.2M | $128.4M | ||
| Q1 24 | $78.2M | $126.5M |
负债/权益比FTHMRIGL
| Q4 25 | 0.15× | 0.13× | ||
| Q3 25 | 0.12× | 0.51× | ||
| Q2 25 | 0.12× | 0.73× | ||
| Q1 25 | 0.12× | 3.23× | ||
| Q4 24 | 0.21× | 18.25× | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-20.7M | — |
| 自由现金流率自由现金流/营收 | -22.8% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-29.4M | — |
8季度趋势，按日历期对齐
经营现金流FTHMRIGL
| Q4 25 | $-20.5M | $22.0M | ||
| Q3 25 | $3.0M | $24.0M | ||
| Q2 25 | $-5.9M | $30.5M | ||
| Q1 25 | $-5.7M | $-893.0K | ||
| Q4 24 | $-4.7M | $14.5M | ||
| Q3 24 | $-330.0K | $21.7M | ||
| Q2 24 | $-3.1M | $302.0K | ||
| Q1 24 | $-947.0K | $-5.0M |
自由现金流FTHMRIGL
| Q4 25 | $-20.7M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $-6.0M | — | ||
| Q1 25 | $-5.8M | — | ||
| Q4 24 | $-4.7M | — | ||
| Q3 24 | $-364.0K | — | ||
| Q2 24 | $-3.1M | — | ||
| Q1 24 | $-948.0K | — |
自由现金流率FTHMRIGL
| Q4 25 | -22.8% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | -4.9% | — | ||
| Q1 25 | -6.2% | — | ||
| Q4 24 | -5.2% | — | ||
| Q3 24 | -0.4% | — | ||
| Q2 24 | -3.5% | — | ||
| Q1 24 | -1.3% | — |
资本支出强度FTHMRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率FTHMRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTHM
| Real Estate Brokerage | $84.9M | 94% |
| Mortgage Segment | $3.4M | 4% |
| Other | $2.3M | 3% |
RIGL
暂无分部数据
